Search
for
Sort by
Research 541–570 of 1000+
- 저출력 레이저 요법 및 침 치료를 이용한 반흔성 탈모 및 원형탈모증에 대한 치험 1례
- Synthesis and in vitro study of 17β-[N-ureylene-N,N′-disubstituted]-4-methyl-4-aza-5α-androstan-3-ones as selective inhibitors of type I 5α-reductase
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Referee report. For: Demographic status and training needs of aesthetic plastic surgeons in government and private hospitals: evidence from Guangdong, China [version 1; peer review: 1 approved with reservations]
- The gene for autosomal dominant hidrotic ectodermal dysplasia (Clouston syndrome) in a large Indian family maps to the 13q11-q12.1 pericentromeric region
- Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) From the Phase 2 and Phase 3 ALLEGRO Clinical Trial Program
- Long-Term Efficacy and Complete Scalp Hair Regrowth in Patients With Alopecia Areata Receiving Ritlecitinib 50 mg QD Up to 3 Years in the ALLEGRO Clinical Trial Program
- 24. 力発揮および操作性からみた下肢運動の一側優位性(神経・感覚,一般口演,第63回日本体力医学会大会)
- Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children
- Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluation.
- Most men choose eyebrows versus scalp hair: Response to Mostaghimi et al., “Evaluation of eyebrow and eyelash regrowth and patient satisfaction in the phase 3 THRIVE-AA2 trial of deuruxolitinib in adult patients with alopecia areata”
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- Ixekizumab shows efficacy and safety in patients who failed biweekly etanercept therapy: Analysis From UNCOVER-2, a phase 3 randomized clinical trial in psoriasis
- The role of candidate pharmacogenetic variants in determining valproic acid efficacy, toxicity and concentrations in patients with epilepsy
- DIAGNOSIS AND THERAPEUTIC MANAGEMENT OF MALASSEZIA DERMATITIS IN A CAT–ACASE REPORT
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- Evaluation of the Topical use of Essential Fatty Acids in Rabbits with Skin Disorders
- Successful treatment of demodicosis with fluralanar in dogs
- Postoperative complicated appendectomy revealing Crohn’s disease in a pediatric patient
- Molluscum Contagiosum in an Epidermoid Cyst
- Protopanaxatirol type ginsenoside Re promotes cyclic growth of hair follicles via inhibiting transforming growth factor β signaling cascades
- Treatment of Hair Loss in the Trichorhinophalangeal Syndrome
- Effect of ethanol extract of plant mixture on hair regeneration in human dermal papilla cells and C57BL/6J mice
- CUTANEOUS T-CELL LYMPHOMA WITH LYMPH NODE METASTASIS IN AN ADULT ADDAX (<i>ADDAX NASOMACULATUS</i>)
- Disseminated tinea incognito due to Trichophyton violaceum in a healthy child
- A Case of Loose Anagen Hair Syndrome in a Southeast Asian Boy
- HIV infection mimicking autoimmune disorder
- Influenza-like symptoms and thrombocytopenia in a teenager
- Do non-prescription products help in managing androgenic alopecia?